Fullerton Fund Management CO Ltd. Abb Vie Inc. Transaction History
Fullerton Fund Management CO Ltd.
- $2.58 Billion
- Q3 2025
A detailed history of Fullerton Fund Management CO Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Fullerton Fund Management CO Ltd. holds 6,025 shares of ABBV stock, worth $1.41 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,025
Previous 1,707
252.96%
Holding current value
$1.41 Million
Previous $316,000
341.46%
% of portfolio
0.05%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,499Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...